XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis - Financials

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.52 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are XTLB's key financials?

XTLB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XTLB recently traded at $2.52. Market cap is $6.39M. P/E ratio is 0.00. Revenue is $0.

XTLB Key Metrics

Key financial metrics for XTLB
MetricValue
Price$2.52
Market Cap$6.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$10.28
52-Week Low$2.12
Volume6
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XTLB News

Recent XTLB Insider Trades

  • EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
  • EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
  • EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.

XTLB Analyst Consensus

XTLB analyst coverage data. Average price target: $0.00.

Common questions about XTLB

What are XTLB's key financials?
XTLB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XTLB recently traded at $2.52. Market cap is $6.39M. P/E ratio is 0.00. Revenue is $0.
Is XTLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.
XTLB

XTLB